Back
ESC Professional Premium Access

Prevalence and clinical correlates of clinical red flags for rare diseases in consecutive patients presenting with HCM phenotype

Session: Hypertrophic cardiomyopathy: not so rare, but not so easy
Topic: Hypertrophic Cardiomyopathy
Speaker: Doctor N. Maurizi (Lausanne, CH)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Niccolo' Maurizi

University Hospital of Lausanne, Lausanne (Switzerland)
4 presentations
0 follower

4 more presentations in this session

Metoprolol improves left ventricular longitudinal function at rest and during exercise in obstructive hypertrophic cardiomyopathy

Speaker: Mrs A. Dybro (Aarhus, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Mavacamten induces a clinical, hemodynamic, and biomarker response beyond the primary endpoint in EXPLORER-HCM: results from a post hoc machine learning analysis

Speaker: Doctor I. Olivotto (Florence, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Temporal trends, characteristics and comorbidities of patients with hypertrophic cardiomyopathy in denmark from 2005-2018: A nationwide cohort study.

Speaker: Doctor C. Zoerner (Copenhagen, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Representativeness of EXPLORER-HCM trial and prevalence of eligibility criteria for Mavacamten in a nationwide cohort

Speaker: Doctor M. Brandao (Vila Nova de Gaia, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Hypertrophic cardiomyopathy: not so rare, but not so easy

Speakers: Doctor N. Maurizi, Mrs A. Dybro, Doctor I. Olivotto, Doctor C. Zoerner, Doctor M. Brandao
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources